Clinical Trials

Accrual Status
Limit to SWOG Trials

1033 Results

View
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0910

A Phase II Study of Epratuzumab in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Precursor B-cell Acute Lymphoblastic Leukemia
Research Committee(s)
Leukemia
Activated
08-15-2010
Closed
07-01-2012
Closed
Phase
Accrual
73%
Published
SWOG Clinical Trial Number
S0941

Phase II Study of Sorafenib (NSC-724772) and Erlotinib (NSC-718781) in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2010
Closed
09-15-2011
ClinicalTrials.gov Registry Number
NCT01093222
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0800

A Randomized Phase II Trial of Weekly Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel) (NSC-736631) With or Without Bevacizumab, Either Preceded by or Followed by Q 2 Week Doxorubicin (A) and Cyclophosphamide (C) Plus Pegfilgrastim (Peg-G) as Neoadjuvant Therapy for Inflammatory and Locally Advanced Her-2/Neu Negative Breast Cancer
Research Committee(s)
Breast Cancer
Activated
04-01-2010
Closed
10-01-2012
Closed
Phase
Accrual
91%
Published
SWOG Clinical Trial Number
S0905

A Phase I / Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma
Status Notes
This study permanently closed to accrual February 15, 2016.
Research Committee(s)
Lung Cancer
Activated
03-15-2010
Closed
02-15-2016
ClinicalTrials.gov Registry Number
NCT01064648
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S0904

Randomized Phase II Study of Docetaxel Followed by Vandetanib (ZD6474) vs. Docetaxel plus Vandetanib in Patients with Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Research Committee(s)
Gynecologic Cancer
Activated
03-15-2010
Closed
08-01-2011
Closed
Phase
Accrual
98%
SWOG Clinical Trial Number
S0916

A Phase II Trial of the Anti-CCR2 Antibody MLN1202 in Patients with Bone Metastases
Research Committee(s)
Early Therapeutics & Rare Cancers
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Lung Cancer
Myeloma
Activated
03-01-2010
Closed
03-15-2011
ClinicalTrials.gov Registry Number
NCT01015560
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0715

Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane Induced Neuropathy
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Cancer Survivorship
Molecular Epidemiology
Activated
09-15-2009
Closed
02-01-2011
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0805

Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without Allogeneic Stem Cell transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL)
Research Committee(s)
Leukemia
Activated
09-01-2009
ClinicalTrials.gov Registry Number
NCT00390793
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0919

A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status Notes
Permanently closed effective 9/15/17.
Research Committee(s)
Leukemia
Activated
08-15-2009
Closed
09-15-2017
ClinicalTrials.gov Registry Number
NCT00840177
Closed
Phase
Accrual
78%
Published
SWOG Clinical Trial Number
S0819

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Status Notes
Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement
Research Committee(s)
Lung Cancer
Activated
07-15-2009
Closed
05-01-2015
ClinicalTrials.gov Registry Number
NCT00946712
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0816

A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma using Interim FDG-PET Imaging
Research Committee(s)
Lymphoma
Activated
07-01-2009
Closed
12-01-2012
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0826

A Phase II Trial of SCH 727965 (NSC 747135) in Patients with Stage IV Melanoma
Research Committee(s)
Melanoma
Activated
07-01-2009
Closed
11-01-2010
ClinicalTrials.gov Registry Number
NCT00937937
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0701

A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori
Research Committee(s)
Prevention & Epidemiology
Activated
06-16-2009
Closed
06-30-2010
ClinicalTrials.gov Registry Number
NCT01061437
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0802

A Randomized Phase II Trial of Weekly Topotecan with and without AVE0005 (Aflibercept; NSC-724770) in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)
Research Committee(s)
Lung Cancer
Activated
05-15-2009
Closed
03-01-2012
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0801

A Phase II Study of Iodine-131 Labeled Tositumomab in Combination With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients with Advanced Stage Follicular Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
04-01-2009
Closed
12-15-2010
Closed
Phase
Accrual
94%
Published
SWOG Clinical Trial Number
S0713

A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-operative Therapy of Rectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-2009
Closed
04-15-2013
ClinicalTrials.gov Registry Number
NCT00686166
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0702

"A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment"
Status Notes
Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Genitourinary Cancer
Lung Cancer
Myeloma
Activated
12-15-2008
Closed
12-13-2013
ClinicalTrials.gov Registry Number
NCT00874211
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
S0703

A Phase II Trial of Azacitidine Plus Gemtuzumab Ozogamicin as Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia
Status Notes
Research Committee(s)
Leukemia
Activated
12-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0809

A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)
Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-2008
Closed
10-01-2012
ClinicalTrials.gov Registry Number
NCT00789958
Closed
Phase
Accrual
54%
Published
SWOG Clinical Trial Number
S0709

A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with Performance Status 2 (PS-2) Selected by Serum Proteomics
Research Committee(s)
Lung Cancer
Activated
12-01-2008
Closed
09-15-2014
ClinicalTrials.gov Registry Number
NCT00661193